|
MIS-C characteristics (N = 57)
| |
|
Age, mean (min–max)
|
9 (2mo–21 years)
|
|
Sex, n (%)
| |
|
Male
|
33 (58)
|
|
Female
|
24 (42)
|
|
Race, n (%)
| |
|
White
|
26 (46)
|
|
Black
|
19 (33)
|
|
Asian
|
3 (5)
|
|
Other
|
11 (19)
|
|
Ethnicity, n (%)
| |
|
Hispanic
|
36 (63)
|
|
MIS-C criteria
| |
|
Evidence of prior SARS-CoV-2 infection/exposure
| |
|
Prior ( +) SARS-CoV-2 PCR
|
27 (47)
|
|
Current ( +) SARS-CoV-2 PCR
|
41 (72)
|
|
Current ( +) SARS-CoV-2 antibody test
|
55 (96)
|
|
Close exposure to individual with COVID-19
|
46 (80)
|
|
Fever, n (%)
|
57 (100)
|
|
Organ involvement, n (%)
| |
|
Cardiac
|
40 (70)
|
|
Ventricular dysfunction
|
14 (35)
|
|
Coronary aneurysm
|
6 (15)
|
|
Vasopressor support
|
14 (35)
|
|
Myocarditis
|
20 (50)
|
|
Gastrointestinal
|
53 (93)
|
|
Respiratory
|
36 (63)
|
|
Neurologic
|
26 (46)
|
|
Dermatologic
|
23 (40)
|
|
Mucocutaneous
|
22 (39)
|
|
Musculoskeletal
|
15 (26)
|
|
Renal
|
12 (21)
|
